Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia

Published:2003-06-12 Issue:1 Volume:71 Page:23-28
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Schiavone Ettore Mariano,De Simone Mariacarla,Palmieri Salvatore,Annunziata Mario,Pocali Barbara,Copia Carolina,D'Amico Maria Rosaria,Vecchio Luigi Del,Ferrara Felicetto

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-0609.2003.00087.x/fullpdf

Reference30 articles.

1. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia;Keating;J Clin Oncol,1991

2. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment;O'Brien;Blood,1993

3. Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemia;Zinzani;Eur J Haematol,1993

4. Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukaemias and low-grade lymphomas;Fenchel;Leuk Lymphoma,1995

5. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy;Keating;Blood,1998

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between Progression-Free Survival and Overall Survival in Chronic Lymphocytic Leukemia: A Literature-Based Analysis;Current Oncology;2015-06-08

2. Bendamustine plus mitoxantrone for relapsed/refractory chronic lymphocytic leukaemia (CLL): results of a multicentre phase II study of the German CLL Study Group (GCLLSG);British Journal of Haematology;2012-05-10

3. Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trialof the Gruppo Italiano per lo Studio dei Linfomi (GISL);Annals of Hematology;2010-09-17

4. Treatment of Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia;Chronic Lymphocytic Leukemia;2008-10-27

5. Chemoimmunotherapy of chronic lymphocytic leukemia;Best Practice & Research Clinical Haematology;2007-09